{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T03:03:10Z","timestamp":1761102190831},"reference-count":72,"publisher":"Walter de Gruyter GmbH","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The balance between reactive oxygen species production and antioxidant activity has an important role in oxidative stress associated diseases such as phenylketonuria (PKU). We aimed in this study to evaluate the possible association between oxidative balance and clinical features of PKU patients.<\/jats:p><jats:p>Twenty patients and 50 healthy subjects were selected. Prooxidant-antioxidant balance (PAB) was measured and phenylalanine (Phe), tyrosine (Tyr), Phe\/Tyr ratio and hematological indices were determined.<\/jats:p><jats:p>A significantly higher PAB value was observed in the patient group (152.0\u00b114.1 HK unit) compared to the controls (88.1\u00b113.88 HK) (p&lt;0.05). There was significant correlation between PAB with serum Phe, Tyr, Phe\/Tyr ratio, white blood cells (WBC) and red blood cells (RBC) counts.<\/jats:p><jats:p>The serum PAB values were higher in patients with PKU and this was associated with the serum Phe and Tyr and Phe\/Tyr ratio. Therefore, because of its low cost and simplicity to perform, PAB value might be considered as a useful monitoring marker among the other tools in these patients.<\/jats:p>","DOI":"10.1515\/jpem-2015-0398","type":"journal-article","created":{"date-parts":[[2016,3,23]],"date-time":"2016-03-23T18:01:06Z","timestamp":1458756066000},"source":"Crossref","is-referenced-by-count":9,"title":["Prooxidant-antioxidant balance in patients with phenylketonuria and its correlation to biochemical and hematological parameters"],"prefix":"10.1515","volume":"29","author":[{"given":"Somayeh","family":"Tavana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrieh","family":"Amini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Saeed","family":"Hakhamaneshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedram","family":"Andalibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammd Saleh","family":"Hajir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azin","family":"Ardalan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Abdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asadollah","family":"Fathollahpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","reference":[{"key":"ref241","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jns.2010.01.016","article-title":"Lipoic acid prevents oxidative stress in vitro and in vivo by an acute hyperphenylalaninemia chemically-induced in rat brain","volume":"292","year":"2010","journal-title":"J Neurol Sci"},{"key":"ref391","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/jnnp.2008.151175","article-title":"Adults with late diagnosed PKU and severe challenging behaviour: a randomised placebo-controlled trial of a phenylalanine-restricted diet","volume":"80","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref411","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/j.ymgme.2009.10.016","article-title":"Pathogenesis of cognitive dysfunction in phenylketonuria: review of hypotheses","volume":"99","year":"2010","journal-title":"Mol Genet Metab"},{"key":"ref481","first-page":"675","article-title":"NOX, the main regulator in oxidative stress in experimental models of phenylketonuria?","volume":"26","year":"2013","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s10545-011-9417-2","article-title":"Oxidative stress in phenylketonuria: future directions","volume":"35","year":"2012","journal-title":"J Inherit Metab Dis"},{"key":"ref501","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bbadis.2005.02.005","article-title":"Oxidative stress in patients with phenylketonuria","volume":"1740","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"ref471","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ymgme.2010.05.017","article-title":"Suboptimal outcomes in patients with PKU treated early with diet alone: revisiting the evidence","volume":"101","year":"2010","journal-title":"Mol Genet Metab"},{"key":"ref681","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s10571-011-9693-2","article-title":"Oxidative stress in phenylketonuria: what is the evidence?","volume":"31","year":"2011","journal-title":"Cell Mol Neurobiol"},{"key":"ref541","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.nbd.2015.04.020","article-title":"Oxidative and nitrative stress in neurodegeneration","volume":"84","year":"2015","journal-title":"Neurobiol Dis"},{"key":"ref291","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1037\/0894-4105.22.4.426","article-title":"Cognitive functions and the antioxidant system in phenylketonuric patients","volume":"22","year":"2008","journal-title":"Neuropsychology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/gim.2013.157","article-title":"Phenylalanine hydroxylase deficiency: diagnosis and management guideline","volume":"16","year":"2014","journal-title":"Genet Med"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ijdevneu.2009.01.001","article-title":"Effect of short- and long-term exposition to high phenylalanine blood levels on oxidative damage in phenylketonuric patients","volume":"27","year":"2009","journal-title":"Int J Dev Neurosci"},{"key":"ref261","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.clinbiochem.2006.10.017","article-title":"A novel assay for the evaluation of the prooxidant-antioxidant balance, before and after antioxidant vitamin administration in type II diabetes patients","volume":"40","year":"2007","journal-title":"Clin Biochem"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ymgme.2010.05.017","article-title":"Suboptimal outcomes in patients with PKU treated early with diet alone: revisiting the evidence","volume":"101","year":"2010","journal-title":"Mol Genet Metab"},{"key":"ref251","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s11011-011-9264-8","article-title":"Regular exercise prevents oxidative stress in the brain of hyperphenylalaninemic rats","volume":"26","year":"2011","journal-title":"Metab Brain Dis"},{"key":"ref531","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1111\/j.1471-4159.2006.03907.x","article-title":"Oxidative stress and neurodegeneration: where are we now?","volume":"97","year":"2006","journal-title":"J Neurochem"},{"key":"ref351","first-page":"591","article-title":"Oxidative stress, hematobiochemical parameters, trace elements and vitamins in dogs with zinc responsive dermatosis","volume":"84","year":"2014","journal-title":"Veterinarski Arhiv"},{"key":"ref581","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ijdevneu.2009.01.001","article-title":"Effect of short- and long-term exposition to high phenylalanine blood levels on oxidative damage in phenylketonuric patients","volume":"27","year":"2009","journal-title":"Int J Dev Neurosci"},{"key":"ref521","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s10545-011-9417-2","article-title":"Oxidative stress in phenylketonuria: future directions","volume":"35","year":"2012","journal-title":"J Inherit Metab Dis"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10571-008-9313-y","article-title":"L-carnitine blood levels and oxidative stress in treated phenylketonuric patients","volume":"29","year":"2009","journal-title":"Cell Mol Neurobiol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/jnnp.2008.151175","article-title":"Adults with late diagnosed PKU and severe challenging behaviour: a randomised placebo-controlled trial of a phenylalanine-restricted diet","volume":"80","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1111\/j.1471-4159.2006.03907.x","article-title":"Oxidative stress and neurodegeneration: where are we now?","volume":"97","year":"2006","journal-title":"J Neurochem"},{"key":"ref361","article-title":"Phenylalanine induces oxidative stress and decreases the viability of rat astrocytes: possible relevance for the pathophysiology of neurodegeneration in phenylketonuria","year":"2015","journal-title":"Metab Brain Dis"},{"key":"ref671","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2005.02.073","article-title":"Mitochondrial damage induced by fetal hyperphenylalaninemia in the rat brain and liver: its prevention by melatonin, Vitamin E, and  Vitamin C","volume":"392","year":"2006","journal-title":"Neurosci Lett"},{"key":"ref111","first-page":"675","article-title":"NOX, the main regulator in oxidative stress in experimental models of phenylketonuria?","volume":"26","year":"2013","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref271","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.clinbiochem.2007.12.008","article-title":"Prooxidant-antioxidant balance as a new risk factor in patients with angiographically defined coronary artery disease","volume":"41","year":"2008","journal-title":"Clin Biochem"},{"key":"ref301","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2005.02.073","article-title":"Mitochondrial damage induced by fetal hyperphenylalaninemia in the rat brain and liver: its prevention by melatonin, Vitamin E, and  Vitamin C","volume":"392","year":"2006","journal-title":"Neurosci Lett"},{"key":"ref611","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jns.2010.01.016","article-title":"Lipoic acid prevents oxidative stress in vitro and in vivo by an acute hyperphenylalaninemia chemically-induced in rat brain","volume":"292","year":"2010","journal-title":"J Neurol Sci"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1136\/jmg.32.12.976","article-title":"Phenylketonuria in a low incidence population: molecular characterisation of mutations in Finland","volume":"32","year":"1995","journal-title":"J Med Genet"},{"key":"ref731","article-title":"Phenylalanine induces oxidative stress and decreases the viability of rat astrocytes: possible relevance for the pathophysiology of neurodegeneration in phenylketonuria","year":"2015","journal-title":"Metab Brain Dis"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4103\/2230-8210.81941","article-title":"Prevalence of neonatal hypothyroidism and phenylketonuria in Southern Thailand: a 10-year report","volume":"15","year":"2011","journal-title":"Indian J Endocrinol Metab"},{"key":"ref341","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.etap.2010.09.003","article-title":"Oxidative stress induced by thyroid dysfunction in rat erythrocytes and heart","volume":"31","year":"2011","journal-title":"Environ Toxicol Pharmacol"},{"key":"ref491","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s10545-010-9043-4","article-title":"Nutritional issues in treating phenylketonuria","volume":"33","year":"2010","journal-title":"J Inherit Metab Dis"},{"key":"ref661","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1037\/0894-4105.22.4.426","article-title":"Cognitive functions and the antioxidant system in phenylketonuric patients","volume":"22","year":"2008","journal-title":"Neuropsychology"},{"key":"ref561","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.mrgentox.2009.07.013","article-title":"Evidence that DNA damage is associated to phenylalanine blood levels in leukocytes from phenylketonuric patients","volume":"679","year":"2009","journal-title":"Mutat Res"},{"key":"ref571","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ymgme.2011.03.019","article-title":"Experimental evidence that phenylalanine is strongly associated to oxidative stress in adolescents and adults with phenylketonuria","volume":"103","year":"2011","journal-title":"Mol Genet Metab"},{"key":"ref711","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.etap.2010.09.003","article-title":"Oxidative stress induced by thyroid dysfunction in rat erythrocytes and heart","volume":"31","year":"2011","journal-title":"Environ Toxicol Pharmacol"},{"key":"ref451","first-page":"1327","article-title":"Long-term treatment for hyperphenylalaninemia and phenylketonuria: a risk for nutritional vitamin B12 deficiency?","volume":"28","year":"2015","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.mrgentox.2009.07.013","article-title":"Evidence that DNA damage is associated to phenylalanine blood levels in leukocytes from phenylketonuric patients","volume":"679","year":"2009","journal-title":"Mutat Res"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11011-006-9035-0","article-title":"Investigation of oxidative stress parameters in treated phenylketonuric patients","volume":"21","year":"2006","journal-title":"Metab Brain Dis"},{"key":"ref331","first-page":"1","article-title":"Relationship between oxidative stress and haematological indices in patients with diabetes in the Ghanaian population","volume":"1","year":"2015","journal-title":"Clin Diabetes Endocrinol"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bbadis.2005.02.005","article-title":"Oxidative stress in patients with phenylketonuria","volume":"1740","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"ref691","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1006\/rtph.2000.1399","article-title":"Concordance of the toxicity of pharmaceuticals in humans and in animals","volume":"32","year":"2000","journal-title":"Regul Toxicol Pharm"},{"key":"ref511","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10571-008-9313-y","article-title":"L-carnitine blood levels and oxidative stress in treated phenylketonuric patients","volume":"29","year":"2009","journal-title":"Cell Mol Neurobiol"},{"key":"ref81","first-page":"1327","article-title":"Long-term treatment for hyperphenylalaninemia and phenylketonuria: a risk for nutritional vitamin B12 deficiency?","volume":"28","year":"2015","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s10571-012-9892-5","article-title":"Role of catalase and superoxide dismutase activities on oxidative stress in the brain of a phenylketonuria animal model and the effect of lipoic acid","volume":"33","year":"2013","journal-title":"Cell Mol Neurobiol"},{"key":"ref281","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.ymgme.2011.08.017","article-title":"Diagnosis, classification, and genetics of phenylketonuria and tetrahydrobiopterin (BH4) deficiencies","volume":"104","year":"2011","journal-title":"Mol Genet Metab"},{"key":"ref201","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ymgme.2011.03.019","article-title":"Experimental evidence that phenylalanine is strongly associated to oxidative stress in adolescents and adults with phenylketonuria","volume":"103","year":"2011","journal-title":"Mol Genet Metab"},{"key":"ref381","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/gim.2013.157","article-title":"Phenylalanine hydroxylase deficiency: diagnosis and management guideline","volume":"16","year":"2014","journal-title":"Genet Med"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.nbd.2015.04.020","article-title":"Oxidative and nitrative stress in neurodegeneration","volume":"84","year":"2015","journal-title":"Neurobiol Dis"},{"key":"ref321","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1006\/rtph.2000.1399","article-title":"Concordance of the toxicity of pharmaceuticals in humans and in animals","volume":"32","year":"2000","journal-title":"Regul Toxicol Pharm"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/j.ymgme.2009.10.016","article-title":"Pathogenesis of cognitive dysfunction in phenylketonuria: review of hypotheses","volume":"99","year":"2010","journal-title":"Mol Genet Metab"},{"key":"ref461","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/jhn.12065","article-title":"Nutrition education tools used in phenylketonuria: clinician, parent and patient perspectives from three international surveys","volume":"27","year":"2014","journal-title":"J Hum Nutr Diet"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/87565641.2012.718816","article-title":"Executive response monitoring and inhibitory control in children with phenylketonuria: effects of expectancy","volume":"38","year":"2013","journal-title":"Dev Neuropsychol"},{"key":"ref421","first-page":"477","article-title":"Tetrahydrobiopterin deficiency among Serbian patients presenting with hyperphenylalaninemia","volume":"28","year":"2015","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref651","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.ymgme.2011.08.017","article-title":"Diagnosis, classification, and genetics of phenylketonuria and tetrahydrobiopterin (BH4) deficiencies","volume":"104","year":"2011","journal-title":"Mol Genet Metab"},{"key":"ref221","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1007\/PL00014392","article-title":"Behaviour in early treated phenylketonuria: a systematic review","volume":"159","year":"2000","journal-title":"Eur J Pediatr"},{"key":"ref701","first-page":"1","article-title":"Relationship between oxidative stress and haematological indices in patients with diabetes in the Ghanaian population","volume":"1","year":"2015","journal-title":"Clin Diabetes Endocrinol"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/jhn.12065","article-title":"Nutrition education tools used in phenylketonuria: clinician, parent and patient perspectives from three international surveys","volume":"27","year":"2014","journal-title":"J Hum Nutr Diet"},{"key":"ref311","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s10571-011-9693-2","article-title":"Oxidative stress in phenylketonuria: what is the evidence?","volume":"31","year":"2011","journal-title":"Cell Mol Neurobiol"},{"key":"ref551","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11011-006-9035-0","article-title":"Investigation of oxidative stress parameters in treated phenylketonuric patients","volume":"21","year":"2006","journal-title":"Metab Brain Dis"},{"key":"ref51","first-page":"477","article-title":"Tetrahydrobiopterin deficiency among Serbian patients presenting with hyperphenylalaninemia","volume":"28","year":"2015","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref591","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1007\/PL00014392","article-title":"Behaviour in early treated phenylketonuria: a systematic review","volume":"159","year":"2000","journal-title":"Eur J Pediatr"},{"key":"ref441","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1136\/jmg.32.12.976","article-title":"Phenylketonuria in a low incidence population: molecular characterisation of mutations in Finland","volume":"32","year":"1995","journal-title":"J Med Genet"},{"key":"ref621","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s11011-011-9264-8","article-title":"Regular exercise prevents oxidative stress in the brain of hyperphenylalaninemic rats","volume":"26","year":"2011","journal-title":"Metab Brain Dis"},{"key":"ref721","first-page":"591","article-title":"Oxidative stress, hematobiochemical parameters, trace elements and vitamins in dogs with zinc responsive dermatosis","volume":"84","year":"2014","journal-title":"Veterinarski Arhiv"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s10545-010-9043-4","article-title":"Nutritional issues in treating phenylketonuria","volume":"33","year":"2010","journal-title":"J Inherit Metab Dis"},{"key":"ref631","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.clinbiochem.2006.10.017","article-title":"A novel assay for the evaluation of the prooxidant-antioxidant balance, before and after antioxidant vitamin administration in type II diabetes patients","volume":"40","year":"2007","journal-title":"Clin Biochem"},{"key":"ref401","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/87565641.2012.718816","article-title":"Executive response monitoring and inhibitory control in children with phenylketonuria: effects of expectancy","volume":"38","year":"2013","journal-title":"Dev Neuropsychol"},{"key":"ref601","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s10571-012-9892-5","article-title":"Role of catalase and superoxide dismutase activities on oxidative stress in the brain of a phenylketonuria animal model and the effect of lipoic acid","volume":"33","year":"2013","journal-title":"Cell Mol Neurobiol"},{"key":"ref431","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4103\/2230-8210.81941","article-title":"Prevalence of neonatal hypothyroidism and phenylketonuria in Southern Thailand: a 10-year report","volume":"15","year":"2011","journal-title":"Indian J Endocrinol Metab"},{"key":"ref641","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.clinbiochem.2007.12.008","article-title":"Prooxidant-antioxidant balance as a new risk factor in patients with angiographically defined coronary artery disease","volume":"41","year":"2008","journal-title":"Clin Biochem"}],"container-title":["Journal of Pediatric Endocrinology and Metabolism"],"original-title":[],"link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2015-0398\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T01:40:11Z","timestamp":1619055611000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2015-0398\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,1]]},"references-count":72,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.1515\/jpem-2015-0398","relation":{},"ISSN":["2191-0251","0334-018X"],"issn-type":[{"value":"2191-0251","type":"electronic"},{"value":"0334-018X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1,1]]}}}